The O-glycans of a recombinant mucin-type protein expressed in insect cell lines derived from Trichoplusia ni (Hi-5) and Spodoptera frugiperda (Sf9) were characterized. The P-selectin glycoprotein ligand-1/mouse IgG 2b (PSGL-1/mIgG 2b ) fusion protein carrying 106 potential O-glycosylation sites and 6 potential N-glycosylation sites was expressed and purified from the Hi-5 and Sf9 cell culture medium using affinity chromatography and gel filtration. Liquid chromatography mass spectrometry (LC-MS) of O-glycans released from PSGL-1/mIgG 2b revealed a large repertoire of structurally diverse glycans, which is in contrast to previous reports of only simple glycans. O-Glycans containing hexuronic acid (HexA, here glucuronic acid and galacturonic acid) were found to be prevalent. Also sulfate (Hi-5 and Sf9) and phosphocholine (PC; Sf9) Oglycan substitutions were detected. Western blotting confirmed the presence of O-linked PC on PSGL-1/mIG 2b produced in Sf9 cells. To our knowledge, this is the first structural characterization of PC-substituted O-glycans in any species. The MS analyses revealed that Sf9 oligosaccharides consisted of short oligosaccharides (<6 residues) low in hexose (Hex) and with terminating N-acetylhexosamine (HexNAc) units, whereas Hi-5 produced a family of large O-glycans with (HexNAc-HexA-Hex) repeats and sulfate substitution on terminal residues. In both cell lines, the core N-acetylgalactosamine was preferentially nonbranched, but small amounts of O-glycan cores with single fucose or hexose branches were found.
Introduction
Insect cell lines are frequently used for recombinant protein production. Two of the most popular cell lines are Sf9 and Hi-5 cells. Sf9 stem from the Spodoptera frugiperda species (Vaughn et al. 1977) and Hi-5 is derived from Trichoplusia ni (Wickham et al. 1992 ). Insect cells have been grown in cultures since the 1950s and they can be maintained in serumfree culture without CO 2 (Grace 1958) . Baculovirus expression vector system is the most common insect cell-based protein production procedure and utilizes a tailored baculovirus, which upon infection dictates the cells to express the desired recombinant protein at high levels. This system has provided a safe and easy route to protein production with high yields (Goosen 1992; Jarvis 1993) . N-glycosylation in mammalian cells is most commonly of the hybrid and complex types, whereas N-glycans of insect cells (Drosophila melanogaster) are mostly of the high-mannose or pauci-mannose type with or without core α1,3/6-fucosylation (North et al. 2006; Aoki et al. 2007; Ten Hagen et al. 2009 ). Early data from insect cells indicated that O-glycans were only of low molecular mass. Several studies on Sf9, Hi-5 and Mamestra brassicae found the T-antigen (Galβ3GalNAcα-O-S/T) and the Tn-antigen (GalNAcα-O-S/T; Thomsen et al. 1990; Lopez et al. 1999) . Previous reports have also suggested the presence of a Galα4Galβ3GalNAc structure in M. brassicae, whereas mainly the T-antigen has been reported previously on O-linked glycans in D. melanogaster embryos (Lopez et al. 1999; Seppo and Tiemeyer 2000; North et al. 2006) . Later studies have successively expanded the number of reported O-glycans in insect cells or whole insect extracts. Breloy et al. (2008) revealed a GlcA3Gal3GalNAc O-glycan in the Drosophila Schneider-2 cell line and Aoki et al. (2008) identified a large number of O-glycans of varying sizes in Drosophila embryos. Extended core 1 and 2 structures as well as a single structure with O-Fuc were reported from these embryos (Aoki et al. 2008) . Several structures were shown to carry glucuronic acid (GlcA), whereas no O-linked glycans terminated with sialic acid were found. Minor species also included O-Glc and O-Man glycans (Aoki et al. 2008) .
Protein glycosylation is of importance for protein folding, stability and activity (Ricardo and Solá 2008) . The glycosylation also influences the pharmacokinetics and immunogenicity of protein biopharmaceuticals (Li and d'Anjou 2009) . When producing recombinant proteins for human therapy, the above must be considered such that a suitable host cell for the protein and application in question is selected. In order to improve the pharmacokinetic characteristics of biopharmaceuticals produced in insect cells and to lower their immunogenicity, "humanized" insect cell lines genetically modified to complement the insect cell glycosylation machinery with the addition or inhibition of different glycosyltransferases have been established (Jarvis et al. 1998; Jarvis 2003) . As a result, recombinant proteins carrying complex-type N-glycans (Tomiya et al. 2004 ) with terminal sialylation can be produced in these modified cell lines. There are conflicting reports on the endogenous capacity of insect cells to sialylate glycoproteins (Marchal et al. 2001; Joosten and Shuler 2003; Palomares et al. 2003) . However, without modifying the cell lines and with the exception of the data from Drosophila embryos, most reports seem to agree on that insect cells have very limited capacity to produce glycans with terminal sialic acid (Marchal et al. 2001 ); a structure found on most mammalian extracellular proteins (Varki 2007) .
The P-selectin glycoprotein ligand-1 (PSGL-1) is a mucinlike protein with tandem repeats rich in serine and threonine -the potential sites for O-glycosylation. PSGL-1 is involved in leukocyte trafficking mediated via binding to P-(CD62P) and E-selectin (CD62E) (Lowe 2003) . The binding of PSGL-1 to P-selectin and chemokine ligand 21 and 19 (CCL21/19) is dependent on the post-translational modification of PSGL-1 with tyrosine sulfate and a sialyl-Lewis x determinant (P-selectin) or tyrosine sulfate and sialylated core 1 (CCL21/19; Carlow et al. 2009 ). We have genetically fused the extracellular part of PSGL-1 to the Fc part of mouse IgG 2b to form a fusion protein (PSGL-1/mIgG 2b ), which we have proposed as a versatile inhibitor of protein-carbohydrate interactions (Gustafsson and Holgersson 2006) .
In this study, PSGL-1/mIgG 2b is used as a probe in order to determine the O-glycosylation of Sf9 and Hi-5 cells. The fusion protein is produced as a dimer and carries as many as 106 potential O-glycan sites, which makes it ideal for identification of the different O-glycans produced by Sf9 and Hi-5 cells.
Results PSGL-1/mIgG 2b is mainly expressed as a heavily glycosylated dimer in Hi-5 and Sf9 cells PSGL-1/mIgG 2b produced in Hi-5 and Sf9 cells was successfully purified as shown in Figure 1 . Staining with Pro Q Emerald (stains glycosylated proteins) followed by Sypro Ruby (stains all proteins) revealed a predominant band with a molecular weight above 180 kDa after affinity chromatography of both Hi-5-and Sf9-produced fusion protein ( Figure 1A , B and E, F, lane 1). Additional proteins of lower molecular weight were further removed during size exclusion chromatography ( Figure 1A , B and E, F, lane 2). Western blotting with anti-mIgG(Fc) (Figure 1C and G) and anti-PSGL-1 ( Figure 1D and H) antibodies confirmed that the high-molecular weight band represents the PSGL-1/mIgG 2b fusion protein. PSGL-1/mIgG 2b produced in Sf9 and Hi-5 have an apparent molecular weight of more than 250 kDa with slightly larger glycoforms of the fusion protein produced Fig. 1 . Western blot and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis of PSGL-1/mIgG 2b fusion protein produced in Sf9 and Hi-5 cells. PSGL-1/mIgG 2b produced in Hi-5 (A-D) and Sf9 (E-H) were analyzed under non-reducing conditions on Tris-acetate 3-8% gels and stained with Pro Q Emerald (A and E) and Ruby (B and F) . Five micrograms affinity-purified (lane 1) and affinity-and size exclusion chromatography-purified (lane 2) PSGL-1/mIgG 2b were loaded on the gel. PSGL-1/mIgG 2b fusion proteins were further analyzed with western blot and stained with anti-mIgG(Fc) (C and G) and anti-PSGL-1 (D and H) antibodies. For western blotting, 0.2 µg affinity-purified (lane 1) and affinity-and size exclusion chromatography-purified (lane 2) PSGL-1/mIgG 2b were used.
The O-glycomes of Hi-5 and Sf9 insect cell lines in Sf9 than in Hi-5. The molecular weight of a nonglycosylated PSGL-1/mIgG 2b dimer is only 117 kDa, indicating that the level of glycosylation is high. Anti-mIgG (Fc)-reactive bands around, or slightly below, the 171-kDa molecular weight (MW) marker ( Figure 1C and G) may represent a degradation product. Prolonged exposure produces anti-PSGL-1 reactive bands of similar size (data not shown). Bands above 460 kDa were also observed on Hi-5 blots stained with anti-mIgG(Fc) ( Figure 1C, lanes 1 and 2) and anti-PSGL-1 ( Figure 1D, lanes 1 and 2) . These bands may be explained by staining of multimers of fusion protein.
Monosaccharide analysis identified GlcA as a major constituent of O-linked oligosaccharides in insect cells
The results of the monosaccharide analysis of hydrolyzed N-and O-glycans of PSGL-1/mIgG 2b produced in Sf9 and Hi-5 insect cell lines are shown in Table I . The observed monosaccharide composition is similar to what previously has been observed on mucin-type proteins in Drosophila embryonic cells (Kramerov et al. 1996) , although the GlcN and Man contents appear to be higher on PSGL-1. The majority of GalN is likely to be derived from O-linked GalNAc through hydrolysis-induced N-deacetylation. The GlcN, Fuc and Man monosaccharides could be derived from N-linked glycans. The identification of HexA (galacturonic and GlcA) suggests that the glycosylation may be more complex than previously reported for Sf9 and Hi-5 insect cells (Thomsen et al. 1990; Lopez et al. 1999; Park et al. 1999) . Approximately 90% of the HexA is represented by GlcA and the remaining part by galacturonic acid (GalA; Table I ). Glc was also detected, but the significance of this observation is hard to appreciate because it is a common contaminant during sample isolation. In order to verify that most of the hexuronic acid (HexA) residues were due to O-linked glycosylation, PSGL-1/mIgG 2b produced in Sf9 cells was PNGase F-treated to release N-glycans, which were analyzed separately. The result of the N-glycan monosaccharide profile was markedly different compared with the total profile, with a complete lack of GalN and HexA (Supplementary data, Table S1 ). This indicated that these residues were mainly derived from O-glycans.
The sialic acid content after mild acidic hydrolysis (i.e. derived from N-linked and O-linked glycans) indicated the presence of both Neu5Ac and Neu5Gc in Sf9 and Hi-5 derived samples, albeit at very low levels. The amount of sialic acid is at least 2-3 orders of magnitude lower than any of the other monosaccharide residues which is close to the background level of the analysis method (Zeleny et al. 2006) .
Mass spectrometric analysis of PSGL-1/mIgG 2b O-glycans O-glycans from PSGL-1/mIgG 2b produced in Sf9 and Hi-5 were released by reductive β-elimination. Reduced nonderivatized glycans were analyzed with liquid chromatography mass spectrometry (LC-MS) in negative and positive modes, whereas permethylated O-glycans were analyzed with direct injection electrospray ionization (ESI)-MS in the positive mode. Tables II and III list the O-glycomes of PSGL-1/ mIgG 2b from Hi-5 and Sf9 with compositions, tentative structures, corresponding masses and retention times. Reducing end HexNAcol, deoxyhexose (dHex) and Hex-HexNAcol were assigned as GalNAcol, Fuc and Galβ3GalNAcol (core 1), respectively, based on monosaccharide (Table I) and lectin chip analysis (Figure 8 ). HexA is unspecified throughout, but is likely to be mainly GlcA based on the monosaccharide analysis (Table I ). The composition of the detected oligosaccharides is in line with the monosaccharide residues detected, showing that the majority of glycans detected contain HexA (Tables II and III) . Hex, HexNAc and Fuc residues are present in addition to the reducing end mucin-type GalNAc residue. Out of 29 and 21 annotated O-glycans in Hi-5 and Sf9, respectively, only four structures from each cell line lacked HexA (Tables II and III) .
The negative-mode LC-MS base peak chromatogram and composite spectra of reduced, non-derivatized O-glycans released from PSGL-1/mIgG 2b produced in Hi-5 and Sf9 cells are shown in Figure 2A and B. The corresponding spectra of permethylated O-glycans analyzed with direct injection ESI-MS are included in the Supplementary data, Figure S1A and B. Table II lists 29 Hi-5 derived O-glycans where HexNAcHexA-(Fuc-)GalNAcol (m/z 747), HexNAc-HexA-GalNAcol (m/z 601) and HexNAc-HexA-Galβ3GalNAcol (m/z 763) are the major ions in the LC-MS spectrum. In Table III , we list 21 tentative Sf9-derived O-glycan structures present in the LC-MS spectrum, in which HexNAc-HexA-GalNAcol (m/z 601) and GalNAc-4HexNAc-HexA-GalNAcol (m/z 804) are the most abundant peaks (see also Figure 6 ). Small amounts of N-linked glycans released by β-elimination were detected in the LC-MS and ESI-MS spectra. These structures are listed in Supplementary data, Table S1B and C, and are annotated in Figure 2 and Supplementary data, Figure S1 .
The majority of extended O-glycans in Sf9 and Hi-5 cells are based on the HexA-GalNAcol core structure A reduced HexNAc (i.e. GalNAcol) was found at the reducing end of the majority of structures. The lowest mass with an [M−H] ion of m/z 384 had the sequence Hex-GalNAcol and was believed to represent the core 1 structure (Galβ3GalNAcol) previously detected in insect cells. Three GalNAcol-based core structures account for all major elongated glycans identified in the O-glycome of Sf9 and Hi-5;
Hex-GalNAcol (tentatively core 1), HexA-GalNAcol and HexA-(dHex-)GalNAcol (Tables II and III) . The latter two are new types of core structures. The tentative core 2 structure, Extensions of the core structure HexA-GalNAcol account for 25 of the 29 structures deduced from Hi-5 and 17 of the 21 deduced from Sf9. As for simple extensions (n ≤ 5), the HexA-GalNAcol core sequence was found to be differently elongated in Hi-5 and Sf9 cells. In both cases, the HexA unit was extended with a HexNAc that was either terminated by the addition of one additional HexNAc (Sf9) or further elongated after addition of a Hex unit (Hi-5). The Tn-antigen (GalNAcol, m/z 222 [M−H]) was not detected in the LC-MS analysis because of the scan range (m/z 383-2000). However, it was not detected in the MS analysis of permethylated O-glycans either (m/z 330 [M+Na] ; Supplementary data, Figure S1A and B). Because the amounts of GalNAcol may be underestimated in the mass spectrometric analysis, western blot was performed with an anti-Tn antibody (HB-Tn1). Hi-5-and Chinese hamster ovary (CHO)-produced PSGL-1/mIgG 2b bound to the anti-Tn antibody ( Figure 3A , lane 2 and 3). In contrast, only faint anti-Tn staining was detected on Sf9 cells, whereas Pichia pastoris-produced PSGL-1/mIgG 2b did not stain at all with the anti-Tn antibody ( Figure 3A , lanes 1 and 4, respectively). CHO is known to produce the Tn-antigen, whereas the negative control, P. pastorisproduced fusion protein is mainly mannosylated (Pahlsson et al. 1994; Gustafsson et al. 2011) . Anti-IgG (Fc-specific) staining shows that similar amounts of fusion protein are loaded on the gels ( Figure 3B, lanes 1-4) . The broader band of the P. pastoris sample ( Figure 3B , lane 4) has been noted before (Gustafsson et al. 2011) . These results indicate that the Tn-antigen is present on the fusion protein produced in Hi-5 cells, whereas we cannot detect it on the fusion protein produced in Sf9 cells. Large O-glycans containing (HexNAc-HexA-Hex)-repeats with terminal sulfate in Hi-5 For the Hi-5-derived O-glycans, the cores described in the section above where often elongated with (HexNAc-HexA-Hex)-repeats (Table II) The O-glycomes of Hi-5 and Sf9 insect cell lines sequences of these structures were deduced from high-quality LC-MS 2 spectra as illustrated in Figure 4A , where the MS 2 spectrum of a Hi-5-derived HexNAc-HexA-Hex-extended
The MS 2 spectrum of m/z 1288 is complex and contains 15 assigned fragments. The location of the fucose was deduced from the fact that the fragment ions at m/z 1142 and 1124 showed that it was terminal and that the fragment ions at m/z 544 and 526 showed that it was located toward the reducing end. The location of the reducing end HexNAcol was deduced by extrapolating this location from smaller structures as seen in LC-MS 2 spectra submitted to the UniCarb-DB database (www.unicarb-db.com, last accessed 20 March 2013).
Additional 80 Da was found added to these extended structures suggesting possible sulfation or phosphorylation (Table II) . The presence of a sulfate group was suggested by the presence of a fragment ion at m/z 81 [HSO 3 ] − rather than a fragment ion at m/z 80 [H 2 PO 3 ] − in the MS 3 spectrum of m/ z 282 (HexNAc + 80) ( Figure 4C ). The presence of a sulfated HexNAc unit was deduced from the fact that the fragment ions at m/z 921 and 939 showed that this was placed terminally. This was also supported by fragment ions at m/z 282 and 300, both identifying a sulfate-substituted HexNAc residue ( Figure 4B ). Since the doubly charged parent ion was fragmented, the analysis circumvented the problem of sulfate migration (Kenny, Issa, et al. 2012) . Sulfation of repeated oligosaccharide units are often found as structural elements in mammalian cells. However, in the Hi-5 cells not only was the repeat different, but data suggested that sulfation only occurred on the terminal HexNAc units and not on internal units, as is the case in mammalian glycosaminoglycans (GAGs). (Figure 5 ) of the late eluting component (RT 16.7 min) was totally different. The detection of the m/z 165 fragment ion implied the presence of a reduced fucose (fucitol), indicating that this is placed at the reducing end of the saccharide. The fragment ion at m/z 323 showed that the HexA unit is directly linked to fucitol and that the HexNAc unit is terminal. In conclusion, the spectrum suggested a HexNAc-HexA-Fucitol structure. The deduction of dHex-ol as fucitol is based on the monosaccharide analysis.
Terminal GalNAc-4HexNAc in Sf9 A family of O-glycans in the LC-MS composite spectrum from Sf9 ( Figure 2B ) was found to carry terminal HexNAcHexNAc. Two core structures HexA-GalNAcol and HexA-(Fuc-)GalNAcol were both found to have the HexNAcHexNAc (Schulz et al. 2002) . Therefore, HexNAc 2 -HexA 1 -GalNAcol was annotated to contain a terminal HexNAc4HexNAc, which is the same composition as LacdiNAc (GalNAcβ4GlcNAc) or chitobiose (GlcNAcβ4GlcNAc). A method for differentiation between terminal GlcNAc and GalNAc using MS 3 of fragment ion at m/z 304 has been proposed (Kenny, Skoog, et al. 2012) . Using this approach on the Sf9 sample, the MS 3 spectrum of fragment ion at m/z 304 suggested a terminal GalNAc residue ( Figure 6B ). Taken together with lectin binding data, we suggest the tentative structure of [M−H] ion at m/z 804 to be GalNAc4HexNAc-HexA-GalNAcol. The annotation of the ESI-MS 2 and MS 3 spectra of the [M+Na] ion of m/z 1038 derived from the corresponding permethylated structure are included as Supplementary data, Figure S2A and B, and supported the annotation of the LC-MS spectrum.
Phosphocholine-substituted O-glycans identified on PSGL-1/mIgG 2b produced in Sf9 cells The negative-mode LC-MS spectrum of Sf9 O-glycans contains several ions with masses that suggest phosphocholine (PC) substitutions ( Figure 2B ). In MS 2 fragmentation of PCsubstituted glycans, an intense [M−H] -59 fragment ion represents partial loss of PC [or loss of a N(CH 3 ) 3 group], which is the characteristic ion of this modification (spectrum not shown). Instead, in positive-mode LC-MS, glycosidic cleavage enabled the deduction of the sequence of PC-containing structures (Table III) Figure 7A . The major fragment ions detected were m/z 369 (loss of PC and one HexNAc residue) Fig. 3 . Anti-Tn western blot analysis of PSGL-1/mIgG 2b fusion protein produced in Sf9, Hi-5, CHO and P. pastoris. PSGL-1/mIgG 2b were analyzed under non-reducing conditions on Tris-acetate 3-8% gels, blotted to nitrocellulose membranes and stained with anti-Tn antibody (A) and anti-mIgG(Fc) (B). Two micrograms purified fusion protein was loaded in the following order, (1) Sf9, (2) Hi-5, (3) CHO and (4) P. pastoris. Positive anti-Tn stain is observed to the PSGL-1/mIgG 2b protein produced in the Hi-5 and CHO cell lines (lanes 2 and 3), whereas the binding is very weak to the Sf9 protein (lane 1) and absent in the P-PM protein (lane 4). The anti-PSGL-1 blot shows that the same amount of protein has been loaded in all lanes (B).
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and m/z 572 (PC and two HexNAc residues), showing that the PC was associated with one of the terminal HexNAc residues. The same PC-HexNAc [M+H] ion of m/z 369 previously has been reported in MS 2 spectra of N-glycans carrying terminal PC in nematodes (Cipollo et al. 2005; Poltl et al. 2007) .
In order to verify the presence of PC-substituted O-glycans on PSGL-1/mIgG 2b produced in Sf9 cells, western blot was performed with the PC-specific antibody (TEPC 15). Sf9-produced PSGL-1/mIgG 2b bound strongly to the anti-PC antibody ( Figure 7B , lane 1). In contrast, no PC substitutions could be detected on Hi-5-produced PSGL-1/mIgG 2b (data not shown), which is in agreement with the LC-MS results. The removal of N-glycans did not change the binding intensity of the anti-PC antibody to PSGL-1/mIgG 2b produced in Sf9, suggesting that most of the PC substitutions are situated on O-glycans ( Figure 7B , cp lanes 1 and 2). The lack of Concanavalin A (Con A) binding to PNGase F-treated PSGL-1/mIgG 2b confirms the complete removal of N-glycans ( Figure 7D, cp lanes 1 and 2) . In order to rule out that PC substitutions were not solely found on recombinant PSGL-1/ The O-glycomes of Hi-5 and Sf9 insect cell lines mIgG 2b but a general modification, western blot was performed on cell lysates of native Sf9 cells ( Figure 7E, lanes 4-7) . Several bands reactive with the anti-PC antibody were detected in the Sf9 cell extract, while medium alone was nonreactive ( Figure 7E , cp lane 7 with lanes 8 and 9). Taken together, the western blots confirm that the PC substitution found on recombinant PSGL-1/mIgG 2b is a structural modification found also on endogenous Sf9 glycoproteins.
Glycan profiling of Sf9-and Hi-5-produced PSGL-1/mIgG 2b using lectin arrays The glycan phenotypes of PSGL-1/mIgG 2b produced in Sf9 and Hi-5 cells were analyzed by a glycan array (Figure 8 ). PSGL-1/mIgG 2b produced in CHO cells, which mainly express mono-and disialylated core 1 O-glycans (Liu et al. 2005) , were used for comparison. The lectins BPL, ABA, Jacalin, PNA, ACA and MPA (for lectin names and their specificity, see Table IV ), which primarily recognizes the core 1 O-glycan structure, all bound to Sf9-and Hi-5-produced PSGL-1/mIgG 2b . The presence of N-acetyllactosamine (LacNAc) and/or poly-LacNAc was indicated by ECA, RCA120, PHA(E) and DSA binding. Very small amounts of terminal Hex-HexNAc (m/z 749 and 925 in Figure 2A and B and Tables II and III) were detected in the LC-MS analysis of O-glycans from Hi-5-and Sf9-produced PSGL-1/mIgG 2b . This lectin binding may therefore reflect the presence of LacNAc on N-linked glycans or cross-reactivity with some of the more common epitopes found on the O-glycans. To our knowledge, lectin binding has not been thoroughly investigated on some of the unusual structures detected in this report. support a HexNAc-HexA-Fucol sequence. The MS 2 spectrum is annotated with CFG black and white cartoons. A symbol key is found in Figure 4 . , suggesting a GalNAc-4HexNAc-HexA-GalNAcol mother structure. The MS 2 spectrum is annotated with CFG black and white notation cartoons. A symbol key is included in Figure 4 . The MS 3 spectrum is annotated using the nomenclature proposed by Domon and Costello (1988) .
The α-Gal-specific GSL IB 4 lectin did not bind any of the fusion protein samples, which indicate that the terminal Hex residues found by MS in Sf9-and Hi-5-derived O-glycans are not α-linked galactose.
The lectins LEL, STL, UDA and WGA bound strongly to both Hi5-and Sf9-produced fusion proteins, whereas PWM bound only Sf9-produced PSGL-1/mIgG 2b . These lectins primarily recognize GlcNAc and oligomers thereof, including, but not exclusively, chitobiose (GlcNAcβ4GlcNAc) and chitin (GlcNAcβ4GlcNAc) n . Secondary binding partners include the N-linked core (Manβ4GlcNAcβ4GlcNAc-N-Asn), poly-LacNAc, LacNAc and sialic acid (Allen and Neuberger 1973; Peters et al. 1979; Yamamoto et al. 1981; Peumans et al. 1984; Kawashima et al. 1990) . No HexNAc-4HexNAc-oligomeric sequences were found on O-linked glycans from recombinant PSGL-1/mIgG 2b in the LC-MS analysis. Terminal GalNAcbinding lectins, WFA, HPA, VVA, DBA, SBA and GSL-I A4, bound to both Hi-5-and Sf9-produced PSGL-1/mIgG 2b . Structures carrying terminal HexNAc were prevalent in the O-glycome of both insect cell lines (Tables II and III) . The lectin array indicated that both terminal GalNAc and GlcNAc were present on the fusion proteins produced in Sf9 and Hi-5 cells. Based on the lectin binding and MS data, we suggest that the terminal HexNAc-4HexNAc sequence in Sf9 represents GalNAc-4HexNAc. Furthermore, while the binding of chitobiose-specific lectins to some extent can be explained by binding to the core of N-linked glycans, the increased binding of the GalNAc-specific lectin WFA to Sf9 glycans indicates the same thing as the MS 3 experiments described, namely that the LacdiNAc-like epitope is particularly prevalent in O-glycans in Figure 4 . Reduced protein samples were analyzed on Tris-acetate 3-8% gels, blotted to nitrocellulose membranes and stained with anti-PC antibody (B), anti-PSGL-1 (C) and Concavalin A (Con A) lectin (D). PNGase F-treatment of PSGL-1/mIgG 2b (lane 2, 0.5 µg) abolished Con A binding, but did not influence anti-PC binding, indicating that the PC substitutions are situated on the O-linked oligosaccharides. Mock-treated Sf9 (lane 1, 0.5 µg), PSGL-1/mIgG2b produced in CHO (lane 3, 0.5 µg) and the PC-carrying A. suum extract (lane 4, 3 µg) were included as controls. SDS-PAGE and blotting was repeated in the same manner as above when analyzing the protein extract (lanes 4-7, 7; 14; 28; 42 µg) from native Sf9 cells (E). Sf9-derived PSGL-1/mIgG 2b (lane 1, 0.5 µg), CHO-derived PSGL-1/mIgG 2b (lane 2, 0.5 µg) and A. suum extract (lane 3, 3 µg) were included as controls. The anti-PC antibody binds to proteins in the Sf9 protein extract, in addition to the Sf9-derived PSGL-1/mIgG 2b and Ascaris extract. Ex-cell 405 and Trichoplusia ni medium -formulation Hink (10% serum) cell medium (lanes 8 and 9; 1.5× the volume of the protein extract was loaded) did not stain with the anti-PC antibody.
The O-glycomes of Hi-5 and Sf9 insect cell lines this sample. To our knowledge, N-linked terminal chitobiose have not been observed previously in Drosophila, Sf9 or Hi-5 cells. This lead us to believe that the chitobiose sensitive lectins are not detecting a terminal epitope in this sample.
Binding to prostate surface antigen (PSA), LCA, AOL, AAL and TJA-II indicates that some of the glycans contain fucose; a notion supported by the monosaccharide profile and MS analyses (Tables I-III) . The LC-MS analyses confirm that many O-glycan structures indeed carry fucose, but no blood group antigen-like structures were observed (Tables II and  III Figure 2A and B). The presence of highmannose N-glycans was suggested by binding to NPA, ConA, GNA, HHL and Calsepa. As expected, CHO-produced PSGL-1/mIgG 2b bound very poorly to these lectins.
Data from the lectin array also indicated the presence of terminal α2,6-linked sialic acid (SSA, TJA-I and, for Hi-5, SNA) on both Sf9-and Hi-5-produced PSGL-1/mIgG 2b , while binding to MAL-I and MAH, which recognizes terminal α2,3-linked sialic acid, was negative.
The lectin-binding pattern may, however, reflect other epitopes than terminal sialic acid. SSA preferably binds GalNAcα (Piller et al. 1990 ), but tolerate capping with sialic acid. SNA binds terminal GalNAc and Gal with and without sialic acid in an α2,6 position (Taatjes et al. 1988 ) and TJA-I binds sialylated or sulfated GalNAc stronger than GalNAc alone (Yamashita et al. 1992) . The presence of terminal HexNAc with sulfate substitution was suggested in the LC-MS analysis of the Hi-5 O-glycome (Table II) , but sialic acid was not detected in either of the insect cell-derived O-glycomes. However, trace amounts of 1,2-diamino-4,5-methylenedioxybenzene (DMB)-labeled sialic acid were detected by reverse-phase high-performance liquid chromatography (RP-HPLC; Table I ).
Discussion
We have investigated the O-glycosylation pattern of insect cell lines T. ni (Hi-5) and S. frugiperda (Sf9)-two of the most utilized insect cell lines for production of recombinant proteins-using the recombinant mucin-type fusion protein PSGL-1/mIgG 2b as a model glycoprotein. There are many benefits of using insect cells for recombinant protein production. Insect cells are inexpensive (high yields with the baculovirus expression system), easy to grow (suspension flasks without CO 2 ), safe (no risk of expanding viruses which can infect humans) and display a more human-like posttranslational modification capacity than bacteria and yeast. Examples of vaccine components which have been successfully produced in insect cells are Human papilloma virus L1 structural proteins produced in T. ni cells (Cervarix ® ) and PSA produced in S. frugiperda cells (Provenge ® ; Cox 2012). Several vaccine candidates are evaluated in clinical trials, but currently no human therapeutic proteins are produced (Cox 2012) . The reason for this is most likely due to insect cells' limited capacity to produce complex and high-mannose-type N-glycans, little or no capacity to sialylate and the risk of producing immunogenic carbohydrate determinants such as core α1,3 fucose (Durocher and Butler 2009) . In this study, we report 29 and 21 O-glycans derived from Hi-5-and Sf9-produced PSGL-1/mIgG 2b , respectively, of which seven share the sequence with previously reported O-glycans in Drosophila embryo extracts (Aoki et al. 2008) , nests of wasps Fig. 8 . Glycan profiling of PSGL-1/mIgG 2b produced in Sf9 and Hi-5 cells using a lectin array. PSGL-1/mIgG 2b from Hi-5 and Sf9 were analyzed together with CHO-produced PSGL-1/mIgG 2b (125 ng/mL of each sample). Binding of fusion protein to lectins is detected as fluorescence intensity. Lectins with similar binding specificity have been highlighted with the same color. Lane 46 is a position marker which is needed for the instrument software and lane 47 represents background signal intensity which is used to calculate the net intensity of each lectin. Used with permission from GP BioSCIENCES. Key for lectins, see Table IV .
The O-glycomes of Hi-5 and Sf9 insect cell lines (Vespula germanica) and hornets (Vespa crabro; Garenaux et al. 2011 ). The remaining O-glycans to our knowledge are reported for the first time in Arthropoda.
The LC-MS analysis of native reduced O-glycans released from the fusion protein PSGL-1/mIgG 2b produced in Hi-5 and Sf9 insect cells revealed that the O-glycomes of these cell lines were complex and diverse (Figure 2A and B, Tables II and  III) . Also, LC-MS analyses of reduced non-derivatized glycans provided more structural information than did direct injection ESI-MS of permethylated glycans (Supplementary data, Figure S1 ). On-line LC equipped with a graphitized carbon column allowed the separation of glycan isomers, which was not possible with direct injection ESI-MS. Further, it was found that LC-MS in negative mode detected substitutions such as sulfate and PC, which were not detected in the permethylated glycan analysis. Possibly these substitutions were lost during the sample preparation after the permethylation step.
A range of core structures was identified in the O-glycome of Hi-5 and Sf9 cells In agreement with previous findings in insect cells, we confirmed by MS and lectin binding the presence of Galβ3GalNAcol, i.e. core 1 (Figures 2 and 8 , Tables II and  III) . The Tn-antigen (GalNAcα-Ser/Thr) has been detected in Sf9 and Hi-5 cells by lectin western blot (Lopez et al. 1999) . In this study, we detected the Tn-antigen in Hi-5 and Sf9 (weakly) by western blot (Figure 3 ) and a lectin array analysis (Sf9 and Hi-5; Figure 8 ), while it was not detected in the MS analyses. This may be explained by the relatively low sensitivity of MS with regard to GalNAcol detection. The HexNAc-HexNAc O-linked core was identified in Drosophila embryos (Aoki et al. 2008 ), but was not detected in the Hi-5 or Sf9 O-glycomes. All but one O-glycan identified on the fusion protein expressed in Hi-5 and Sf9 cells were based on GalNAcol cores: Galβ3GalNAcol, HexA-GalNAcol, HexA-(Fuc-)GalNAcol and extensions thereof (Tables II and III) . The HexA-GalNAcol core structure and linear extensions thereof have not previously been detected in insect cells. Previously, a tentative core 2 structure was reported to be present in the Drosophila embryo O-glycome in minute amounts (Aoki et al. 2008) . We detected it in Hi-5 and Sf9 O-glycans as well, although in very small amounts. The presence of O-linked fucose in Hi-5 was suggested from the identification by MS of the HexNAc-HexA-Fucitol structure ( Figure 5) . Aoki et al. (2008) have reported an isomeric branched O-Fuc structure (GlcNAcβ3(GlcAβ4)Fuc) in the Drosophila embryo. In addition, we identified in the O-glycome of both Hi-5 and Sf9 the unusual structure in which a Fuc was branching off the core GalNAcol ( Figure 4A ). While this type of structure was not reported in Drosophila embryo extracts, the same single extension of Fuc was reported recently in V. germanica (German wasp) and has previously been found in a mutant form of C. elegans (Palaima et al. 2010; Garenaux et al. 2011) .
A series of HexA containing structures identified in the O-glycomes of Hi-5 and Sf9 cells Aoki et al. (2008) previously reported an abundance of O-glycans carrying GlcA in Drosophila embryos . In contrast, very low amounts of GlcA were found in Drosophila embryo N-glycans (Aoki et al. 2007 ). GlcA does not seem to be present at all in the O-linked salivary mucins of common wasp (Garenaux et al. 2011) . The LC-MS analysis detected a large proportion of O-glycans containing HexA on Hi-5-and Sf9-produced PSGL-1/mIgG 2b , indicating that HexA is a common substitution in lepidopteran insect cell O-glycans (Figure 2A and B, Tables II and III) . In agreement with the previous report of GlcA in Drosophila, the monosaccharide analysis of glycans from Sf9-and Hi-5-produced PSGL-1/ mIgG 2b indicated that the HexA residue is mainly GlcA with only small amounts of GalA. Previously, GlcAβ3Galβ3GalNAc-O and Galβ3(GlcAβ4)GalNAc-O have been reported in Drosophila embryo extracts (Aoki et al. 2008; Aoki and Tiemeyer 2010) . One can speculate if terminal GlcA in insect cells has analogous roles to sialic acid in vertebrate cells, since sialic acid is in low abundance, if found at all, in insects cells. However, GlcA contributed only weakly to the negative surface charge of Schneider-2 Drosophila cells, which is in contrast to the effect of sialic acid on vertebrate cell surfaces (Breloy et al. 2008) . While the lectin chip results indicated that terminal α2,6-linked sialic acid was present on PSGL-1/ mIgG 2b produced in both Hi-5 and Sf9 cells (Figure 8) , the ESI-MS and LC-MS analyses on permethylated and native reduced glycans, respectively, found no evidence of O-glycans containing sialic acid (Figure 2A and B) . Small amounts of sialic acid were detected by RP-HPLC of DMB-derivatized sialic acids (Table I) . However, the concentrations found were much lower than for the other monosaccharides detected in the high-pH anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) analysis. Given the low amounts detected, sialic acids may not be biologically relevant in these cell lines. Recent data suggest that sialylation is a specialized and developmentally regulated process in the nervous system of Drosophila (Koles et al. 2009 ). However, an accumulated body of evidence suggests that most insect cells are not capable of extending glycans with sialic acid unless genetically modified (Voss et al. 1993; Marchal et al. 2001; Hillar and Jarvis 2010) . The detected sialic acids may thus come from co-purified serum glycoproteins or be explained by incorporation of sialic acid from the cell media via a salvage pathway (Hillar and Jarvis 2010; Ghaderi et al. 2012) .
Terminal Hex, Hex-HexNAc and GalNAc4HexNAc
In the LC-MS analysis of released O-glycans, we find ions derived from the uncommonly reported sequences of insect cells, namely Hex, Hex-HexNAc and HexNAc-HexNAc. These sequences may correspond to a number of different determinants as suggested by lectin binding, although the identity of individual ions cannot be fully confirmed with the lectins. O-Linked glycans with terminal Gal have been found mainly as part of core 1 structures in Sf9, Hi-5 and Drosophila embryos (Lopez et al. 1999; Aoki et al. 2008) . In this study, the presence of core 1 was confirmed by LC-MS and lectin binding. Also low amounts of Hex-(Hex-HexNAc-) GalNAcol (e.g. the [M−H] − ion at m/z 749 in Hi-5 and Sf9) and Hex-HexNAc-HexA-Galβ3GalNAcol (the [M−H] − ion at m/z 925 in Hi-5) were found in the LC-MS spectra. In the Hi-5 sample, there were also MS 2 fragment ions that gave linkage information, i.e. Hex-(Hex-4HexNAc-)GalNAcol. These structures may bind to the ECA and RCA120 lectins, which recognize terminal Galβ4GlcNAc (LacNAc) determinants. However, the binding of ECA and RCA120 may be mainly mediated by N-glycans or cross-reactivity with some of the more common epitopes found on the O-glycans. Small amounts of N-linked terminal Gal have been reported in the form of LacNAc (Galβ4GlcNAc) in Drosophila embryos and LacNAc has been found on a recombinantly expressed IgG molecule in T. ni cells (Hsu et al. 1997; Aoki and Tiemeyer 2010) . To our knowledge, LacNAc has not been reported previously on glycoproteins produced in Sf9 cells.
In both Sf9-and Hi-5-derived O-glycans, the majority of the structures carry terminal HexNAc. Lectin binding supports the presence of terminal GalNAc, including terminal GalNAc in an α-linkage. In Sf9, Hi-5 and Drosophila embryos, the Tn-antigen, GalNAcα-Ser/Thr and extensions thereof are the only reported O-glycans carrying GalNAc, which we also detect with anti-Tn antibody on the fusion protein produced in Hi-5 and very weakly in Sf9 (Figure 3) . In Drosophila, a range of minor O-glycans have been reported to carry terminal GlcNAc or HexNAc (Aoki et al. 2008 ).
In the Sf9-derived samples, we detect structures carrying terminal GalNAc-4HexNAc ( Figure 6A and B) . HexNAcHexNAc on extended structures has been reported in O-glycans of V. Germanica (German wasp), but in Drosophila, the disaccharide has only been found in the HexNAcGalNAcol form (Aoki et al. 2008; Garenaux et al. 2011) . The strong WFA binding to PSGL-1/mIgG 2b produced in Sf9 cells indicates that the HexNAc-4HexNAc determinant of the HexNAc-4HexNAc-HexA-GalNAcol O-glycan may represent LacdiNAc. PWM and other lectins which recognize GlcNAcβ4GlcNAc in both Sf9 and Hi-5 have no obvious binding partner among O-glycans identified by MS (Figure 2) , which lead us to suggest that the main binding target of this lectin is the N-linked core or may represent cross-reactive binding to some of the O-glycans carrying terminal HexNAc (Tables II and III) .
N-Linked LacdiNAc has been reported as a minor component in Drosophila embryos and bee venom, but neither N-linked nor O-linked LacdiNAc has previously been found in Sf9 or Hi-5 cells (Altmann et al. 1999; Aoki and Tiemeyer 2010) .
Fucose-containing structures identified in the glycomes of Sf9 and Hi-5 cells Many of the glycans of PSGL-1/mIgG 2b produced in Sf9 and Hi-5 cells contain fucose as suggested by monosaccharide analysis and lectin binding. LC-MS analysis of O-glycans from Hi-5 and Sf9 revealed several fucose-containing structures including a single core Fucitol structure in Hi-5 (HexNAc-HexA-Fucitol) and HexA-(Fuc-)GalNAcol and extended structures thereof in both cell lines (Tables II and  III) . The lectin array binding may thus reflect binding to the unusual fucose extension of the GalNAc-O core as identified by LC-MS ( Figure 4A ) in this study. No blood group-like structures were observed in LC-MS analysis of the O-glycans. Because recombinant PSGL-1/mIgG 2b was also N-glycosylated, additional lectin binding (e.g. lectin AOL) may likely reflects core α1,3 (Hi-5) and α1,6 (Hi-5 and Sf9) fucosylation of the N-glycans (Staudacher et al. 1992; Tomiya et al. 2003) . Our finding that PSGL-1/mIgG 2b produced in Hi-5 is resistant to PNGase F treatment (data not shown), while Sf9-produced is sensitive ( Figure 7D, cp. lanes 1 and 2) is consistent with the notion that α1,3 core fucosylation inhibits PNGase F activity (Tretter et al. 1991) .
Several structures extended with sulfated and non-sulfated (HexNAc-HexA-Hex)-repeats in Hi-5 Previously not observed in insect cells, we report a collection of relatively large GAG-like glycans with and without terminal sulfate containing a variable number of (HexNAc-HexAHex)-repeats ( Figure 4A and B and Table II ). All sulfate groups were found on terminal HexNAc but not internal HexNAc. The sulfated HexNAc-HexA-Hex carrying structures may stem from GAGs, but we could not find the GalNAcβ4GlcAβ3Galβ3Galβ4Xyl linker region or its fragments in recombinant PSGL-1/mIgG 2b from Hi5 or Sf9. This linker region has been readily observed in C. elegans after β-elimination (Guerardel et al. 2001; Aoki et al. 2008) . The HexNAc-HexA-Hex sequence is found only once in the GAG chain and not as joined repeats, which we find among the O-glycans derived from PSGL-1/mIgG 2b produced in Hi-5 cells. Several of the O-glycans carry fucose linked to the core GalNAcol, which is not observed in common GAGs. Sulfated N-linked and O-linked glycoproteins seem to be rare in insect cells, but the existence and function of sulfated GAGs and proteoglycans have been successfully studied in Drosophila, and genes involved in GAG chain synthesis and sulfation have been characterized (Seppo and Tiemeyer 2000; Toyoda et al. 2000) . Sulfated GAGs have been shown to play an important role during development of Drosophila (Toyoda et al. 2000) . Sulfated glycans and proteins appear to be intimately involved in the interactions between selectins and their counter-receptors (Yeh et al. 2001) . Selectin homologs have been found in Drosophila (Leshko-Lindsay and Corces 1997). Because we find sulfated glycans on human PSGL-1 expressed in Hi-5 and Sf9, it is possible that sulfation of selectin counter-receptors may contribute to the selectin binding also in insects.
A conserved immune evasion motif of nematodes and trematodes found on O-glycans produced in Sf9 cells Phosphocholine substitution of N-glycans is a conserved modification in nematode and trematode species (Lochnit et al. 2000; Harnett et al. 2010) . Recently N-linked PC was also reported in the flatworm Echinococcus granulosus which is closely related to trematodes (Paschinger et al. 2012) . PC has been reported to be involved in one of several immune evasion strategies of these parasites. For instance, the rodent filarial nematode Acanthocheilonema viteae produce a PC-substituted 62 kDa Excretory-Secretory glycoprotein, ES-62, which has been demonstrated to clonally activate certain signal transduction elements in B lymphocytes, leading to inhibition of B cell
The O-glycomes of Hi-5 and Sf9 insect cell lines receptor-induced activation and subsequent B cell proliferation (Deehan et al. 2001; . PC substitutions have also been reported in Dictyocaulus viviparous (bovine lungworm) and Ascaris suum ( pig roundworm), and in nonparasitic nematode C. elegans (Cipollo et al. 2002; Poltl et al. 2007; Kooyman et al. 2009 ). Expressed sequence tag analysis of Brugia malayi and Onchocerca volvulus revealed that proteins homologous to ES-62 were present in these human filarial nematodes, which are responsible for major morbidity in the tropics (Harnett et al. 2003) .
To our knowledge, PC substitutions have not been observed in insects previously although phosphoethanolaminesubstituted glycans have been observed in Locusta migratoria (N-linked) and V. germanica (O-linked) (Hard et al. 1993; Maes et al. 2005) . O-Linked PC have been suggested in the nematode Onchocerca gibsoni, but no structural evidence for its presence were presented (MacDonald et al. 1996) . The LC-MS spectrum of O-glycans derived from Sf9 contains several ions with masses suggesting PC substitutions ( Figure 2B ). Western blotting with the anti-PC antibody confirmed the presence of PC on the fusion protein and binding was preserved after N-glycan removal ( Figure 7B ). Further, anti-PC western blot reveals the presence of PC in cell lysate of un-transformed Sf9 cells, which shows that the PC substitution is not unique for the recombinant PSGL-1/mIgG 2b ( Figure 7E ). The function of the O-linked PC is not known but the presence of carbohydrate-linked PC in arthropod as well as parasitic and non-parasitic nematodes imply a broader function of PC than the immunoregulation.
Currently, work is being performed to produce small molecule derivates or peptide mimetics of ES-62, which carry PC for use as anti-inflammatory drugs (Harnett et al. 2010) . The molecules which mimic the activity of ES-62 are less likely to induce immune responses than the ES-62 glycoprotein, but natural anti-PC antibodies which exist in humans may still be a problem . The finding of PC-substituted O-glycans may negatively influence the bioactivity in vivo of recombinant proteins produced in Sf9 cells. However, this also opens up a novel route for high yieldproduction of PC-containing glycoproteins that may be used for human therapy of allergy and autoimmune diseases.
In conclusion, we show that the O-glycomes of Sf9 and Hi-5 cells are far more complex than previously reported. Besides known O-glycan structures, novel O-glycan structures containing GlcA (Hi-5 and Sf9), sulfate (Hi-5 and Sf9) and PC (Sf9) were identified. In addition, O-Fuc glycans and core structures with a fucose branch were detected. Several of the glycans that we detected have previously been shown to be immunomodulatory (i.e. PC) and immunogenic (e.g. core α1,3-Fuc) (van Die and Cummings 2006; Altmann 2007; . Thus, these insect cells should be used with caution when it comes to production of recombinant therapeutic proteins for human use, and glycoengineering of these cell lines to "humanize" also their O-glycomes should be encouraged.
Material and methods

Lectins and antibodies
Goat anti-mIgG Fc, goat anti-mIgG Fc-horseradish peroxidase (HRP), goat anti-mIgG(Fab)-HRP, mIgA kappa antiphosphorylcholine (clone TEPC-15), goat anti-mIgA(α-chain specific)-HRP and goat anti-mIgM-HRP antibody were obtained from Sigma-Aldrich (St Louis, MO). Biotinylated Con A was purchased from Vector Laboratories (Burlingame, CA). HRPconjugated NeutrAvidin was purchased from Pierce (Rockford, IL). The mouse anti-PSGL-1 antibody, CD162 (clone KPL-1), was bought from BD PharMingen (San Diego, CA). Mouse anti-Tn (clone HB-Tn1,) was purchased from Dako (Glostrup, Denmark).
Expression plasmids
The PSGL-1/mIgG 2b expression plasmid was constructed by inserting the PSGL-1/mIgG 2b encoding DNA sequence into the cloning cassette of pIZ/V5-His (Invitrogen, Carlsbad) using HindIII and NotI (Gustafsson 2005) .
Engineered insect cell lines
Hi-5 insect cells were engineered as described previously (Gustafsson 2005) , and Sf9 cells were generated in the same manner. The zeocin selection drug (Invitrogen) was used at a concentration of 0.75 mg/mL. Stable transfectants were bulkselected with removal of dead cells using density centrifugation on Ficoll.
Cell culture Cells were maintained in Trichoplusia ni medium -formulation Hink medium (BD Biosciences, Franklin Lakes, NJ) supplemented with zeocin at a concentration of 0.75 mg/mL, penicillin (Gibco, Invitrogen) at 50 U/mL and streptomycin (Gibco, Invitrogen, Carlsbad) at 50 µg/mL. Cells were grown in tissue culture flasks (T-75/T-175; BD Falcon, BD Biosciences) at 27°C without CO 2 in an incubator without humidity control. Cells were split 1:3 every second or third day. Larger cultures were performed in Erlenmeyer flasks (Ilmabor TGI, Ilmenau, Germany) in a shaker incubator under the same conditions as above at 100 rpm, but with the addition of Pluronic F-68 (Sigma-Aldrich), 1 g/L, in order to prevent foaming. Cultures were stopped when the fraction of dead cells reached 40-50% as measured by Trypan blue (Invitrogen) staining in a Bürker chamber.
Purification of PSGL-1/mIgG 2b
Cell culture supernatants containing PSGL-1/mIgG 2b were prepared for chromatography by centrifugation (5020 × g, 30 min) and filtration through a 0.2-µm PES filter-top (TPP, Zürich, Switzerland) or Millipore PES (Billerica, CA), followed by addition of 1 mL/L of protease inhibitors (Sigma-Aldrich) and sodium azide (Sigma-Aldrich) to a final concentration of 0.02% (w/v). Prepared supernatants were stored at 4°C until further processed.
PSGL-1/mIgG 2b was affinity purified from prepared supernatants on a goat anti-mIgG (whole molecule)-agarose column (Sigma-Aldrich) using a Bio-Rad (Hercules, CA) BioLogic LP system running at low pressure. The samples were loaded at a flow rate of 0.5-0.7 mL/min, where after the column was washed with 12 column volumes (CV) of phosphate buffered saline and eluted with 24 CV of 3 M NaSCN (Sigma-Aldrich) at a flow rate of 1 mL/min. Eluted fractions were analyzed by western blotting using goat anti-mIgG Fc-specific antibodies and pooled accordingly. Following dialysis in molecular porous membrane tubing (MWCO 12-14 kDa; Spectrum Laboratories, Breda, the Netherlands) against distilled H 2 O, samples were lyophilized and resuspended in 1-2 mL of H 2 O.
In order to purify the fusion protein further, gel filtration was performed on a Sephacryl S-300 16/60 column (GE Healthcare Life Sciences, Uppsala, Sweden) coupled to an ÄKTA FPLC system (GE Healthcare Life Sciences). Elution buffer was 3 M NaSCN. Eluted fractions were divided in two pools based on protein size as determined by western blotting. The protein concentration of purified samples was determined using enzyme-linked immunosorbent assay (ELISA). The purity of fusion proteins was assessed by staining sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gels with Pro Q Emerald 300 glycoprotein stain (Invitrogen) in combination with SYPRO Ruby protein stain (Invitrogen).
Preparation of protein extract from cell lysates of untransformed Sf9 cells The Sf9 cells were grown in T-flasks in the manner described in section Cell culture but without selection agent zeocin. Lyophilized cell pellet (0.1 g) was dissolved in solubilizing buffer: 10 mM Tris-Cl (Sigma-Aldrich), pH 7.5, 150 mM NaCl (Merck, Darmstadt, Germany), 1% Triton X-100 (Sigma-Aldrich), Protease Inhibitor cocktail 1 mL/L (Sigma-Aldrich), 1 mM ethylenediaminetetraacetic acid (Merck) on ice for ca 15 min until pellet was dissolved completely. The cell lysate was centrifuged and the supernatant was stored in −80°C until further use.
Protein concentration determination with bicinchoninic acid staining protocol The concentration of protein extracts was determined with Micro bicinchoninic acid Protein Assay Reagent (Pierce) according to the instructions of the manufacturer. Briefly, unknown samples and protein standards were treated in parallel and developed in a colorimetric assay. The concentration of the unknown samples was deduced from a standard absorbance curve determined with a spectrometer.
Enzyme-linked immunosorbent assay
The concentration of PSGL-1/mIgG 2b was determined by a two-antibody sandwich ELISA as described previously (Gustafsson et al. 2011 ).
SDS-PAGE and western blot
Proteins were separated under reducing or non-reducing conditions on precasted 3-8% Tris-acetate NuPAGE gels in an Xcell SureLock mini-cell device (Invitrogen) as described previously (Gustafsson et al. 2011) . The antibodies used are described in section Lectins and antibodies.
Endoglycosidase treatment of glycoproteins Glycoprotein samples (10 µg) were treated with 500 U Peptide:N-glycosidase F (PNGase F) in supplied buffers according to the manufacturer's protocol (cat no P0705S, New England Biolabs, Ipswich, MA). Treatment included boiling of the sample in denaturing buffer for 10 min followed by enzyme treatment for 24 h at 37°C.
Monosaccharide composition analysis using HPAEC-PAD Monosaccharide composition analysis was performed by the Glycotechnology Core Resource at the University of California, San Diego. Fifty micrograms of purified PSGL-1/mIgG 2b fusion proteins produced in Sf9 and Hi-5 insect cell lines was hydrolyzed with 2 M trifluoroacetic acid (TFA) at 100°C for 6 h to release and cleave glycans into monosaccharides. TFA was removed with 50% isopropanol. The released and dried sugars were dissolved in water and analyzed by HPAEC-PAD using a CarboPac PA-1 column (4 × 250 mm) on a Dionex ICS 3000 system. HexA standards (GlcA, GalA and iduronic acid) and common monosaccharide standards (Fuc, Glc, Gal, Man, GalN and GlcN) were used for calibration of the instrument and identification of the above-mentioned monosaccharides in the PSGL-1/mIgG 2b samples. Elution of neutral carbohydrates was performed with 16 mM NaOH, while acidic sugars were eluted with a gradient of sodium acetate (75-200 mM in 20 min) in 16 mM NaOH. The monosaccharide content in mole/mole protein was calculated using the apparent molecular weight of PSGL-1/mIgG 2b as determined by western blot.
Sialic acid determination
Sialic acid determination was performed by the Glycotechnology Core Resource at the University of California, San Diego. Twenty-five micrograms purified PSGL-1/mIgG 2b fusion proteins produced in Sf9 and Hi-5 insect cell lines was dissolved in 2 M acetic acid and heated to 80°C for 3 h to release sialic acids. Released sialic acid were collected by ultrafiltration through a 3000 MWCO filter and dried. The sialic acids were derivatized with DMB at 50°C for 2.5 h. The samples were analyzed by RP-HPLC, with on-line fluorescence detection. Identification and quantification were based on known amounts of derivatized N-acetylneuraminic acid and N-glycolylneuraminic acid injected in parallel to unknown samples. A water sample, treated in parallel with the real samples in all preparatory steps, was used as a negative control.
Chemical release and permethylation of O-linked glycans from purified PSGL-1/mIgG 2b Oligosaccharides to be analyzed in ESI-MS were released and permethylated as described (Carlstedt et al. 1993; Hansson and Karlsson 1993) . For LC-MS analysis, the glycans were released by β-elimination and analyzed as reduced structures. Briefly, lyophilized PSGL-1/mIgG 2b proteins were dissolved in water to 1 mg/mL concentration. The glycans were released in a solution of 1.5 M NaBH 4 in 50 mM KOH and incubated overnight at 60°C. The reaction was stopped with addition of acetic acid. The released glycans were desalted on AG50WX8 cation exchange beads (Bio-Rad) packed on top of a C18 Zip-tip or home-made mini columns made of pipette tips and glass wool (Millipore). Samples were eluted with water and dried in a SpeedVac. Borate complexes were removed with 1% acetic acid in methanol and subsequent vacuum centrifugation five times. The dried glycans were dissolved in water for analysis on LC-MS.
Mass spectrometry ESI-MS in the positive-ion mode was performed as described previously using an LCQ ion-trap mass spectrometer
The O-glycomes of Hi-5 and Sf9 insect cell lines (Liu et al. 2005 ) (Thermo Fischer Scientific, San Jose, CA). Samples were dissolved in methanol:water, 1:1, and introduced into the mass spectrometer at a flow rate of 5 µL/min. Nitrogen was used as sheath gas and the needle voltage set to 4.5 kV. The temperature of the heated capillary was set to 200°C. The samples were loaded manually (ca. 8 µL) with a Hamilton syringe and injected into the instrument at a flow rate of 5 µL/min. MS n was performed with a collision energy set to 50%. LC-MS was performed on a graphitized carbon column coupled to an LTQ LC/MS n ion trap instrument (Thermo Fischer Scientific). The method was previously developed by Karlsson et al. (2004) . The column was packed with 5 µm Hypercarb particles (Thermo, Hypersil-Keystone, Runcorn, UK). The glycans were eluted with a gradient from 0 to 40% acetonitrile in 8 mM NH 4 HCO 3 buffer and detected in the negative mode by full scans (m/z 383-2000) followed by MS 2 scans of the most intense ions. The needle voltage was −3.2 kV. Preselected ions were isolated for MS n fragmentation by collision induced dissociation with the collision energy set to 30%. Air was used as a sheath gas and mass ranges were defined for each of the specific structures to be analyzed. The determination of terminal GalNAc was performed as described previously (Kenny, Skoog, et al. 2012) . The identification of sulfate substitution was done with sulfate standard (GalNAc-4-O-sulfate, Dextra Laboratories, Reading, UK) and phosphoric acid (Fluka).
Interpretation of mass spectra
The original spectra were exported from Qualbrowser 1.2 (Thermo Finnigan) as ASCII text files and imported into GlycoWorkBench [downloadable free java tool, http ://download.glycoworkbench.org/ (Ceroni et al. 2007 (Ceroni et al. , 2008 ]. Carbohydrate structures were drawn manually and fragment ions (B, C, Z, Y and cross-ring fragments) were calculated with the fragment tool of the program. The fragments were matched with the peak lists using the annotate tool. Calculations were also performed in ChemDraw Std 11.0 (CambridgeSoft). The MS 2 fragment spectra for all structures listed in this paper were submitted to UniCarb-DB (www.unicarb-db.com, last accessed 20 March 2013) , to allow access to the full dataset (Hayes et al. 2011) .
Glycan profiling of insect cell produced PSGL-1/mIgG 2b using lectin arrays Lectin chip analysis was performed on purified PSGL-1/ mIgG 2b produced in Sf9 and Hi-5 insect cell lines by GP BioSCIENCES (Yokohama, Japan). Purified PSGL-1/mIgG 2b produced in CHO-K1 cells was included for comparison (Liu et al. 2005) . Briefly, cyanine-labeled glycoproteins in several dilutions were applied to the LecChip™ surface, which contains 45 different immobilized lectins. An evanescent-field is generated above the LecChip™ array and binding of a ligand to the lectins is detected by measuring the fluorescence intensity in the GPB Glycostation™ Reader 1200. For a detailed technical description, see Kuno et al. (2005) . For a complete listing of the lectins immobilized on the chip and their reported specificities, see Table IV . For full name and references of the specificity of each lectin we refer to GP BioSCIENCES (www.gpbio.jp, last accessed 20 March 2013), and Lectin Frontier DataBase (http://riodb.ibase.aist.go.jp/ rcmg/glycodb/LectinSearch, last accessed 20 March 2013). We have included references in this paper when additional specificities exist for some lectins which are not listed by GP BioSCIENCES in Table IV .
Supplementary data
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